Academic literature on the topic 'Dermatology diseases'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Dermatology diseases.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Dermatology diseases"

1

Kombaté, Koussake, Julienne Noude Técléssou, Bayaki Saka, Abla Sefako Akakpo, Koudjouka Odette Tchangai, Abas Mouhari-Toure, Garba Mahamadou, Waguena Gnassingbé, Aurel Abilogun-Chokki, and Palokinam Pitché. "Prevalence and Factors Associated with Self-Medication in Dermatology in Togo." Dermatology Research and Practice 2017 (2017): 1–5. http://dx.doi.org/10.1155/2017/7521831.

Full text
Abstract:
Objective. This study aimed to determine the prevalence of and factors associated with self-medication in dermatology in Lomé, Togo.Methods. We conducted an analytical cross-sectional study from February to April 2016 in 2 dermatology departments in Lomé. Univariate and multivariate logistic regression models were carried out to identify possible factors associated with self-medication.Results. A total of 711 patients were included in the study. The mean age (±SD) of the patients was26.6±6.9years and the sex ratio (male/female) was 0.6. The main dermatologic diseases recorded were immunoallergic dermatoses (39.7%) and infectious skin diseases (22.6%). Two-thirds (481/711; 66.7%) of the patients had practiced self-medication before consultation in dermatology units. In multivariate analysis, factors associated with self-medication were female sex (aOR = 1.44; 95% CI =[1.01, 2.05]), duration of dermatologic disease more than one year (aOR = 1.79; IC =[1.19, 2.68]), adnexal dermatoses (aOR = 2.31; 95% IC =[1.03–5.21]), keratinization disorders (aOR = 4.23; 95% CI =[1.36–13.13]), and fungal skin infections (aOR = 5.43; 95% CI =[2.20, 13.38]).Conclusion. Our study confirms that self-medication practice is very common among patients with dermatologic diseases in Lomé and has identified associated factors.
APA, Harvard, Vancouver, ISO, and other styles
2

Phillips, Charles M., William A. Burke, Bethany Bergamo, and Susan Mofrad. "Review of Teleconsultations for Dermatologic Diseases." Journal of Cutaneous Medicine and Surgery 4, no. 2 (April 2000): 71–75. http://dx.doi.org/10.1177/120347540000400206.

Full text
Abstract:
Background: Telemedicine has been increasingly used in some areas to provide consultation for isolated populations that might otherwise have difficulty accessing specialty care. Little information exists on what types of patients or diseases are being seen in dermatology telemedicine consultation services. Objective: To review our consultations done over a regional telemedicine network with an emphasis on looking at what type of patient, cutaneous diseases, and diagnostic or therapeutic recommendations were made. Results: Between August 1992 and December 1997, 796 teleconsultations were done. The most common diagnoses made were eczemas, follicular based diseases, skin infections, and skin tumours. Steroids were the most commonly recommended therapy, along with antibiotics, antihistamines, and antifungal therapy. Diagnostic recommendations commonly made were a skin biopsy and potassium hydroxide preparation. Conclusion: Common skin problems were seen by our dermatology teleconsultation service. A significant number of diagnostic biopsies and potassium hydroxide preparations were recommended. The efficacy of telemedicine in the delivery of dermatologic care is reviewed.
APA, Harvard, Vancouver, ISO, and other styles
3

Tripathi, Shivani V., and Kieron S. Leslie. "Autoinflammatory Diseases in Dermatology." Dermatologic Clinics 31, no. 3 (July 2013): 387–404. http://dx.doi.org/10.1016/j.det.2013.04.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kaczmarczyk, Robert, Felix King, Tilo Biedermann, and Alexander Zink. "What’s driving dermatology? Contribution title analysis of the largest German Dermatology Congress 2019." DIGITAL HEALTH 7 (January 2021): 205520762110121. http://dx.doi.org/10.1177/20552076211012138.

Full text
Abstract:
Background Every two years, German-speaking dermatologic specialist groups gather in Berlin to share the latest developments at Germanýs largest dermatologic conference, the Annual Meeting of the Germany Society of Dermatology (DDG). Because this conference has a lasting effect on dermatologic practice and research, understanding what is moving the specialist groups means understanding what is driving dermatology in Germany. Methods We used word network analysis to compile and visualize the information embedded in the contribution titles to the DDG Annual Meeting in 2019. We extracted words, contributing cities and inter-connections. The data was standardized, visualized using network graphs and analyzed using common network analysis parameters. Results A total of 5509 words were extracted from 1150 contribution titles. The most frequently used words were “therapy”, “patients”, and “psoriasis”. The highest number of contributions came from Hamburg, Berlin and Munich. High diversity in research topics was found, as well as a well-connected research network. Conclusions Focus of the well-connected German-speaking dermatology community meeting 2019 was patient and therapy centered and lies especially on the diseases psoriasis and melanoma. Network graph analysis can provide helpful insights and help planning future congresses. It can facilitate the choice which contributors to include as imbalances become apparent. Moreover, it can help distributing the topics more evenly across the whole dermatologic spectrum.
APA, Harvard, Vancouver, ISO, and other styles
5

Lucchina, Leslie, Mary Wilson, and Lynn Drake. "Dermatology and the recently returned traveler: infectious diseases with dermatologic manifestations." International Journal of Dermatology 36, no. 3 (March 1997): 167–81. http://dx.doi.org/10.1046/j.1365-4362.1997.00150.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ulman, Catherine A., Stephen Bruce Binder, and Nicole J. Borges. "Assessment of medical students’ proficiency in dermatology: Are medical students adequately prepared to diagnose and treat common dermatologic conditions in the United States?" Journal of Educational Evaluation for Health Professions 12 (May 17, 2015): 18. http://dx.doi.org/10.3352/jeehp.2015.12.18.

Full text
Abstract:
This study assessed whether a current medical school curriculum is adequately preparing medical students to diagnose and treat common dermatologic conditions. A 15-item anonymous multiple choice quiz covering fifteen diseases was developed to test students’ ability to diagnose and treat common dermatologic conditions. The quiz also contained five items that assessed students’ confidence in their ability to diagnose common dermatologic conditions, their perception of whether they were receiving adequate training in dermatology, and their preferences for additional training in dermatology. The survey was performed in 2014, and was completed by 85 students (79.4%). Many students (87.6%) felt that they received inadequate training in dermatology during medical school. On average, students scored 46.6% on the 15-item quiz. Proficiency at the medical school where the study was performed is considered an overall score of greater than or equal to 70.0%. Students received an average score of 49.9% on the diagnostic items and an average score of 43.2% on the treatment items. The findings of this study suggest that United States medical schools should consider testing their students and assessing whether they are being adequately trained in dermatology. Then schools can decide if they need to re-evaluate the timing and delivery of their current dermatology curriculum, or whether additional curriculum hours or clinical rotations should be assigned for dermatologic training.
APA, Harvard, Vancouver, ISO, and other styles
7

James, William D. "Imported Skin Diseases in Dermatology." Journal of Dermatology 28, no. 11 (November 2001): 663–66. http://dx.doi.org/10.1111/j.1346-8138.2001.tb00059.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

High, Whitney A., and Francisco G. Bravo. "Emerging Diseases in Tropical Dermatology." Advances in Dermatology 23 (2007): 335–50. http://dx.doi.org/10.1016/j.yadr.2007.07.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lupi, Omar, and Stephen K. Tyring. "Tropical dermatology: viral tropical diseases." Journal of the American Academy of Dermatology 49, no. 6 (December 2003): 979–1000. http://dx.doi.org/10.1016/s0190-9622(03)02727-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Pang, Katie R., Jashin J. Wu, Omar Lupi, and Stephen K. Tyring. "Tropical dermatology: fungal tropical diseases." Journal of the American Academy of Dermatology 50, no. 3 (March 2004): P103. http://dx.doi.org/10.1016/j.jaad.2003.10.337.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Dermatology diseases"

1

Vives, Vilagut Roser. "Design of an exploratory development plan for the assessment of the activity of drugs for the treatment of chronic inflammatory dermatological diseases." Doctoral thesis, Universitat Autònoma de Barcelona, 2016. http://hdl.handle.net/10803/400199.

Full text
Abstract:
Antecedents: El procés de desenvolupament d'un fàrmac des del descobriment a la comercialització és una seqüència complexa que es pot perllongar més de deu anys. La duració, taxa de fracassos i les fites varien molt depenent del tipus de fàrmac i la seva indicació. Hipòtesis: Durant el desenvolupament de noves entitat moleculars (NEM) pel tractament tòpic de malalties dermatològiques inflamatòries (MDI), l'establiment d'un pla de desenvolupament clínic utilitzant dissenys d'estudis de Prova de Concepte (PdC) eficients portarà a obtenir dades robustes i concloents en un curt període de temps, amb mínims requeriments de dades no-clíniques i clíniques, minimitzant l'exposició al producte en investigació dels subjectes en assajos clínics, assegurant la seva seguretat. Objectiu: Identificar l'aproximació més eficient per explorar l'activitat clínica d'una NEM pel tractament tòpic de les MDI en quant a fiabilitat dels resultats, requeriments de dades no-clíniques i clíniques i subjectes exposats, temps per obtenir dades d'activitat i inversió requerida. Mètodes: S'ha dut a terme una revisió de guies regulatòries de la ICH, l'EMA i la FDA i dels informes d'avaluació públics de productes tòpics dermatològics per tal d'identificar els objectius d'un pla de desenvolupament exploratori i els estudis no-clínics i clínics requerits per a iniciar els estudis de PdC. Es va dur a terme una revisió d'assajos clínics publicats de productes dermatològics tòpics en dermatitis atòpica (DA) i psoriasis publicats durant el període de gener 2003-desembre 2013, per tal de descriure els estudis utilitzats per obtenir una PdC en termes de disseny, nombre de subjectes, duració i tipus de variables i identificar els dissenys de PdC més rellevants en DA i psoriasis. Per cada tipus de disseny identificat s'ha proposat un pla de desenvolupament amb recomanacions, estimant costos i duració, comparant les diferents aproximacions. Resultats: Hi ha molt poca informació sobre com planificar el desenvolupament d'una NEM pel tractament de la DA i la psoriasis per la via tòpica malgrat les diferencies respecte dels productes per via sistèmica en termes de exposició sistèmica i seguretat podrien impactar en els plans de desenvolupament. S'han revisat un total de 59 estudis en DA i 40 en psoriasis i s'han identificat 3 tipus d'estudis principals con a rellevants per a avaluar l'activitat d'un producte aplicat per via tòpica: Estudi aleatoritzat, paral·lel inter-subjecte, Estudi aleatoritzat paral·lel intra-subjecte i estudis farmacodinàmics. Per la DA, s'han proposat dos escenaris, amb els dissenys inter-subjecte i intra-subjecte com a PdC i per la psoriasis s'ha proposat un tercer escenari amb un estudi de placa com a PdC. Després de tenir en compte totes les dades prèvies requerides en cadascun dels escenaris i les seves característiques, s'ha proposat un escenari implementant un estudi intra-subjecte per la DA i un amb un estudi de placa per la psoriasis com les aproximacions més eficients en terme de costos i temps fins a obtenir una prova d'activitat clínica d'una NEM especialment quan es tracta d'un nou mecanisme d'acció. Conclusions: El disseny del estudi de PdC s'hauria d'establir molt aviat quan es planeja el desenvolupament ja que impactarà en tot el pla de desenvolupament. Algunes de les aproximacions s'han identificat com a més eficients, encara que hi ha diferents factors que poden influenciar. Una guia regulatòria amb els requeriments generals pel desenvolupament de productes tòpics dermatològics seria útil per ajustar la quantitat de proves no-clíniques i clíniques de forma que garantissin la seguretat dels subjectes exposats durant els assajos clínics al mateix temps que evitaria l'ús excessiu de recursos, facilitant el desenvolupament, fent-lo més eficient i predictible.
Background: The process of developing a drug from discovery to the market is a complex sequence of milestones that may take more than ten years. The duration, rate of failures and milestones vary greatly depending on the type of drug and the indication. Hypothesis: During the development of new molecular entities (NME) aimed for the topical treatment of inflammatory dermatological diseases (IDD), setting up an exploratory clinical development plan objective using efficient proof of concept (PoC) study designs, leads to obtaining robust and conclusive data in a short period of time, with minimal requirements of non-clinical and clinical data and minimizing the exposure of subjects participating in clinical trials to the investigational product, thus ensuring their safety. Objective: To identify the most efficient approach to explore the clinical activity of a NME for the topical treatment of IDD in terms of reliability of the results, non-clinical and clinical data requirements and in terms of exposed subjects, time to obtain activity data and investment required. Methods: A systematic review of regulatory guidelines issued by the ICH, EMA and FDA, as well as public assessment reports of topical dermatological products was done to identify the objectives of an exploratory development, and non-clinical and clinical studies required to initiate PoC studies. A systematic review of clinical trials of topical dermatological products in Aropic Eczema (AE) and Psoriasis published in the period January 2003-December 2013, to describe the type of designs used to obtain a PoC in terms of designs, number of patients, duration, type of variables and identify the most relevant clinical trial designs for PoC in AE and/or psoriasis was performed and for each type of design identified, a development plan with recommendations was proposed, estimating costs and duration and comparing the different approaches. Results: There is little information on how to plan the development of a NME for the treatment of AE or psoriasis by the topical route despite differences with respect to systemically administered products in terms of systemic exposure and safety issues may impact development plans. A total of 59 studies in AE and 40 in psoriasis were summarized and 3 main types of studies identified as relevant to assess the activity of a product applied topically on the skin: Randomized, parallel inter-subject study, Randomized, parallel, intra-subject comparison and Pharmacodynamic studies. For AE, two scenarios were proposed, where inter-subject and intra-subject studies were the PoC designs and for psoriasis a third scenario was proposed with a psoriasis plaque test as a PoC. After accounting for all previous data needed in each of the scenarios, and the particular features of development, an scenario implementing an intra-subject design for AE and with a psoriasis plaque test for psoriasis were proposed as the most efficient in terms of time and costs till a proof of clinical activity of a NME especially when it has a new mechanism of action. Conclusions: The design of the PoC study should be established early when planning the development as it will impact on the whole plan. Some approaches have been identified as more efficient although this may be influenced by different factors. A general regulatory guidance for early stage development requirements specific for topical dermatological products would be useful to adjust the amount of non-clinical testing to an extent that guaranties the safety of subjects exposed during clinical trials at the same time that avoids excessive use of resources, easing the development process and making it more efficient and predictable.
APA, Harvard, Vancouver, ISO, and other styles
2

Badial, Peres Ramos [UNESP]. "Astenia dérmica regional hereditária equina: diagnóstico, ocorrência no Brasil e caracterização clinica." Universidade Estadual Paulista (UNESP), 2013. http://hdl.handle.net/11449/108390.

Full text
Abstract:
Made available in DSpace on 2014-08-13T14:50:32Z (GMT). No. of bitstreams: 0 Previous issue date: 2013-08-22Bitstream added on 2014-08-13T18:01:17Z : No. of bitstreams: 1 000725296_20150101.pdf: 109418 bytes, checksum: cebf9f97c8e08074ee65a1e7f67f9863 (MD5) Bitstreams deleted on 2015-01-05T11:00:50Z: 000725296_20150101.pdf,Bitstream added on 2015-01-05T11:01:48Z : No. of bitstreams: 1 000725296.pdf: 956123 bytes, checksum: 50d72cefdb85fffba1d5001620776c3f (MD5)
Este estudo foi realizado para caracterizar os achados dermatológicos, oftalmológicos e morfológicos da pele de cavalos com Astenia Dérmica Regional Hereditária Equina (HERDA) e padronizar um ensaio de “High Resolution Melting” (HRM), para determinar a ocorrência de heterozigotos. As avaliações e a padronização do HRM foram realizadas em cinco cavalos afetados (GA) e cinco não afetados (GC). Adicionalmente, cinco animais heterozigotos (GH) foram utilizados para padronizar o HRM. A ocorrência de heterozigotos foi determinada em 690 animais. Diversas regiões da pele foram mensuradas com cutímetro no GA e GC. Biópsias de pele foram submetidas aos exames histopatológico e ultraestrutural. Avaliação histopatológica foi realizada por dois patologistas. O exame oftalmológico incluiu, além das avaliações rotineiras, aferição dos diâmetros da córnea, paquimetria e biometria. Foi extraído DNA do sangue colhido do GA, GC, GH e de 690 cavalos e o HRM foi validado. Observou-se menor espessura de pele no GA. A sensibilidade e especificidade do diagnóstico histopatológico da pele dependeram do avaliador e da região, respectivamente. Foram observados menor espessura e maior curvatura e diâmetros da córnea no GA. O HRM apresentou elevadas acurácia e precisão. A frequência de heterozigotos foi de 4,7%. Apesar do padrão regional dos sinais dermatológicos, a diminuição da espessura da pele não é regional. Para o diagnóstico histopatológico, recomenda-se realizar biópsia de pele no pescoço, garupa ou dorso. A relevância clínica dos achados oftalmológicos deve ser investigada. O ensaio de HRM padronizado será útil na seleção dos acasalamentos, visando minimizar a ocorrência da doença
The present study was conducted to characterize the dermatological, ophthalmological, and morphological findings from horses affected with Hereditary Equine Regional Dermal Asthenia (HERDA) and to standardize a High Resolution Melting (HRM) genotyping assay to determine the frequency of carriers. The evaluations and HRM standardization were performed in five affected (AG) and five non-affected (CG) horses. Additionally, five heterozygous (HG) horses were used to HRM standardization. The frequency of carriers was determined in 690 horses. Several skin regions of both groups were measured with a cutimeter Skin biopsies were submitted to histopathological and ultrastructural evaluations. Histopathological evaluation was performed by two pathologists. Ophthalmology included, besides the routine evaluations, corneal diameters measurement, pachymetry, and biometry. HRM was validated using purified DNA from blood samples of the AG, CG, HG and 690 horses. Skin thickness decrease was observed in the AG. Histopathological sensitivity and specificity to diagnose HERDA was dependent on the evaluator and region, respectively. HERDA horses exhibited decreased corneal thickness and increased corneal curvature and corneal diameters. The HRM assay resulted in high accuracy and precision. The estimated carrier frequency was 4.7%. Despite of the regional pattern of the dermatological signs, the decrease of skin thickness from HERDA horses is not regional. Skin samples of the neck, croup or back are recommended to diagnose HERDA. The relevance of the ocular findings should be further investigated. The standardized HRM assay will be useful in the management of breeding programs to minimize the occurrence of this disease
APA, Harvard, Vancouver, ISO, and other styles
3

Badial, Peres Ramos. "Astenia dérmica regional hereditária equina : diagnóstico, ocorrência no Brasil e caracterização clinica /." Botucatu, 2013. http://hdl.handle.net/11449/108390.

Full text
Abstract:
Orientador: Alexandre Secorun Borges
Banca: Carlos Alberto Hussni
Banca: João Pessoa Araújo Junior
Banca: Luiz Claudio Nogueira Mendes
Banca: Paulo Henrique Jorge da Cunha
Resumo: Este estudo foi realizado para caracterizar os achados dermatológicos, oftalmológicos e morfológicos da pele de cavalos com Astenia Dérmica Regional Hereditária Equina (HERDA) e padronizar um ensaio de "High Resolution Melting" (HRM), para determinar a ocorrência de heterozigotos. As avaliações e a padronização do HRM foram realizadas em cinco cavalos afetados (GA) e cinco não afetados (GC). Adicionalmente, cinco animais heterozigotos (GH) foram utilizados para padronizar o HRM. A ocorrência de heterozigotos foi determinada em 690 animais. Diversas regiões da pele foram mensuradas com cutímetro no GA e GC. Biópsias de pele foram submetidas aos exames histopatológico e ultraestrutural. Avaliação histopatológica foi realizada por dois patologistas. O exame oftalmológico incluiu, além das avaliações rotineiras, aferição dos diâmetros da córnea, paquimetria e biometria. Foi extraído DNA do sangue colhido do GA, GC, GH e de 690 cavalos e o HRM foi validado. Observou-se menor espessura de pele no GA. A sensibilidade e especificidade do diagnóstico histopatológico da pele dependeram do avaliador e da região, respectivamente. Foram observados menor espessura e maior curvatura e diâmetros da córnea no GA. O HRM apresentou elevadas acurácia e precisão. A frequência de heterozigotos foi de 4,7%. Apesar do padrão regional dos sinais dermatológicos, a diminuição da espessura da pele não é regional. Para o diagnóstico histopatológico, recomenda-se realizar biópsia de pele no pescoço, garupa ou dorso. A relevância clínica dos achados oftalmológicos deve ser investigada. O ensaio de HRM padronizado será útil na seleção dos acasalamentos, visando minimizar a ocorrência da doença
Abstract: The present study was conducted to characterize the dermatological, ophthalmological, and morphological findings from horses affected with Hereditary Equine Regional Dermal Asthenia (HERDA) and to standardize a High Resolution Melting (HRM) genotyping assay to determine the frequency of carriers. The evaluations and HRM standardization were performed in five affected (AG) and five non-affected (CG) horses. Additionally, five heterozygous (HG) horses were used to HRM standardization. The frequency of carriers was determined in 690 horses. Several skin regions of both groups were measured with a cutimeter Skin biopsies were submitted to histopathological and ultrastructural evaluations. Histopathological evaluation was performed by two pathologists. Ophthalmology included, besides the routine evaluations, corneal diameters measurement, pachymetry, and biometry. HRM was validated using purified DNA from blood samples of the AG, CG, HG and 690 horses. Skin thickness decrease was observed in the AG. Histopathological sensitivity and specificity to diagnose HERDA was dependent on the evaluator and region, respectively. HERDA horses exhibited decreased corneal thickness and increased corneal curvature and corneal diameters. The HRM assay resulted in high accuracy and precision. The estimated carrier frequency was 4.7%. Despite of the regional pattern of the dermatological signs, the decrease of skin thickness from HERDA horses is not regional. Skin samples of the neck, croup or back are recommended to diagnose HERDA. The relevance of the ocular findings should be further investigated. The standardized HRM assay will be useful in the management of breeding programs to minimize the occurrence of this disease
Doutor
APA, Harvard, Vancouver, ISO, and other styles
4

Casas, Fernando Constantino. "A seborrheic dermatitis in pygmy goats." Thesis, University of Cambridge, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.385334.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wäster, Larsson Petra. "UVA/B induced redox alterations and apoptosis in human melanocytes." Doctoral thesis, Linköpings universitet, Dermatologi och venerologi, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-8880.

Full text
Abstract:
Malignant melanoma is one of the most rapidly increasing cancers and accounts for about three-quarter of all skin cancer deaths worldwide. Despite compelling evidence that ultraviolet (UV) irradiation causes melanoma the knowledge how various wavelength spectra affect the balance between proliferation and apoptosis controlling the homeostasis of the melanocyte population is still limited. The aim of this thesis was to elucidate the regulation of UVA/B induced apoptotic signaling in human epidermal melanocytes in vitro in relation to redox alterations and antioxidant photoprotection. UVA irradiation induced changes in plasma membrane stability, decreased cell proliferation and increased apoptosis. In comparison, melanocyte plasma membrane was markedly resistant to UVB irradiation although apoptosis was triggered. Thus, UVA irradiation should not be overlooked as an etiologic factor in melanoma development. Further, after irradiation with UVA/B we found alterations in redox state manifested by a reduction of intracellular GSH levels, translocation of nuclear factor-κB from the cytosol to the nucleus, an increase of γ-glutamylcysteine synthetase, the rate-limiting enzyme in GSH synthesis, and an increased apoptosis frequency. α-Tocopherol provided photoprotection through several modes of action affecting redox alterations and signaling, stabilizing the plasma membrane, and decreased proliferation and apoptosis rate, while β-carotene did not show the same protective capacity. Altogether, α-tocopherol might be a useful substance in protecting melanocytes from UV induced damage. We demonstrate UVA/B irradiation to activate the intrinsic pathway of apoptosis in melanocytes where translocation of Bcl-2 family proteins to the mitochondria modulates the apoptosis signal. Interestingly, the anti-apoptotic Bcl-2 family proteins generally thought to be attached to membranes, were localized in the cytosol before UV irradiation and translocated to the mitochondria in the surviving population, which might be a critical event in preventing apoptotic cell death. Lysosomal cathepsins were released to the cytosol acting as pro-apoptotic mediators upstream of activation and translocation of Bax to the mitochondria. When melanocytes were exposed to UVA, p53 participated in apoptosis regulation through interaction with Bcl-2 family proteins, while UVB induced p53-transcriptional activity and apoptosis involving lysosomal membrane permeabilization. Thus, depending on the UV wavelength p53 mediated apoptosis in melanocytes by transcriptional dependent or independent activity. These results emphasize p53 as an important pro-apoptotic component in the regulation of apoptosis. This thesis gives new insight in the harmful and various effects of different wavelengths within the UV spectrum on human melanocytes in vitro. Improved knowledge of the apoptosis regulatory systems in melanocytes might lead to a better understanding of the formation of pigment nevi and malignant melanoma and, in the future, provide better strategies to prevent and eliminate tumor development and progression.
APA, Harvard, Vancouver, ISO, and other styles
6

Venning, Vanessa Ann. "Bullous pemphigoid : clinical and pathogenetic studies." Thesis, University of Oxford, 1993. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.334938.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Souza, Tatiana Mello de. "Dermatopatias não-tumorais em cães: bases para o diagnóstico e dados de prevalência em Santa Maria, Rio Grande do Sul (2005-2008)." Universidade Federal de Santa Maria, 2009. http://repositorio.ufsm.br/handle/1/4036.

Full text
Abstract:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
The current study stemmed from the interest in improving the diagnostic capabilities of a team consisting of two small animal clinicians and four veterinary pathologists from the Laboratório de Patologia Veterinária of the Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do Sul (RS), Brazil; it was conducted from March 2005 to December 2008 as part of a doctoral project entitled "Non-tumorous dermatopathies in dogs" and was divided in two parts. The first part consists of an illustrated literature review on the histological aspects of the skin of dogs and cats, aimed to serve as a tool for dermatopathology, and on the methods applied to the dermatological diagnosis in small animals, with emphasis in the laboratory tests that support the diagnosis. The second part consists of the determination of the prevalence of dermatopathies in dogs in the municipality of Santa Maria, Rio Grande do Sul, Brazil. In this second part there is a pictorial collection, in the format of an atlas, of the main gross and histopathological aspects, that, in association with other criteria, allowed the diagnosis of the non-tumorous dermatopathies herein described. To accomplish that, the canine dermathological clinical cases seen at the Hospital Veterinário Universitário of UFSM and at a private practice from Santa Maria were followed up from March 2005 to June 2008. During this period 480 dogs with dermatological problems were examined; in 393 (81.9%) it was possible to establish a definitive diagnosis and in 87 (18.1%) the diagnosis was inconclusive. Four hundred and twenty four primary diagnosis and 78 secondary diagnosis were performed in the 393 dogs with conclusive diagnosis, totaling 502 diagnosis. The distribution of the diagnosis according to the categories of diagnosed dermatopathies was as follows: Allergic (190/502 [37.8%]), bacterial (103/502 [20.5%]), parasitic (97/502 [19.3%]), environmental (28/502 [5.6%]), mycotic (20/502 [4.0%]), endocrine (13/502 [2.6%]), keratinization defects (11/502 [2.2%]), psychogenic (9/502 [1.8%]), acquired alopecias (6/502 [1.2%]), autoimmune (6/502 [1.2%]), inherited (6/502 [1.2%]), pigmentary abnormalities (1/502 [0.2%], nutritional (1/502 [0.2%]), and sundry conditions (11/502 [2.2%]). In general, the ten most frequently diagnosed non-tumorous dermatopathies in decreasing order of frequency were: Atopy, flea bite allergic dermatitis, superficial bacterial folliculitis, demodectic mange, deep bacterial folliculitis/furunculosis, sarcoptic mange, myiasis, food allergy, pyotraumatic dermatitis, and Malassezia dermatitis. These 10 conditions together made up approximately for 75% of all canine skin diseases diagnosed in the current study. Such a result supports the view that a few skin diseases make up for the most part of the dermatological clinical cases seen in dogs from Santa Maria.
Este estudo derivou do interesse no aperfeiçoamento do diagnóstico dermatológico de uma equipe formada por dois clínicos de pequenos animais e por quatro patologistas veterinários vinculados ao Laboratório de Patologia Veterinária da Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do Sul (RS), Brasil; foi conduzido no período de março de 2005 a dezembro de 2008, faz parte do projeto de doutorado intitulado Dermatopatias não-tumorais em cães e foi dividido em duas partes. A primeira parte consiste de uma revisão de literatura ilustrada sobre os aspectos histológicos da pele de cães e gatos como ferramenta para dermatopatologia e sobre métodos de diagnóstico dermatológico aplicados para pequenos animais, com ênfase em exames laboratoriais que servem de apoio diagnóstico. A segunda parte consiste na determinação da prevalência das dermatopatias nãotumorais em cães do município de Santa Maria, RS, Brasil. Nessa segunda parte há um apanhado fotográfico, no formato de um atlas, dos principais aspectos macroscópicos e microscópicos, que, juntamente com outros critérios, permitiram os diagnósticos das dermatopatias não-tumorais aqui descritas. Para isso, foram acompanhados os atendimentos dermatológicos no Hospital Veterinário Universitário da UFSM e de um consultório veterinário particular no período de março de 2005 a junho de 2008. Durante esse período foram atendidos 480 cães com problemas dermatológicos. Desses, em 393 (81,9%) foi possível estabelecer o diagnóstico definitivo e em 87 (18,1%) o diagnóstico não foi conclusivo. Esses 393 cães com diagnóstico conclusivo totalizaram 502 diagnósticos, 424 diagnósticos primários e 78 diagnósticos secundários. A distribuição dos diagnósticos em relação às categorias de dermatopatias diagnosticadas foi a seguinte: dermatopatias alérgicas (190/502 [37,8%]), dermatopatias bacterianas (103/502 [20,5%]), dermatopatias parasitárias (97/502 [19,3%]), dermatopatias relacionadas ao ambiente (28/502 [5,6%]), dermatopatias fúngicas (20/502 [4,0%]), dermatopatias endócrinas (13/502 [2,6%]), defeitos da ceratinização (11/502 [2,2%]), dermatopatias psicogênicas (9/502 [1,8%]), alopecias adquiridas (6/502 [1,2%]), dermatopatias auto-imunes (6/502 [1,2%]), dermatopatias hereditárias (6/502 [1,2%]), anormalidades pigmentares (1/502 [0,2%], dermatopatias nutricionais (1/502 [0,2%]) e outras dermatopatias (11/502 [2,2%]). No geral, as 10 principais dermatopatias não-tumorais, em ordem decrescente de freqüência, foram: atopia, dermatite alérgica à picada de pulga, foliculite bacteriana superficial, sarna demodécica, foliculite bacteriana profunda/furunculose, sarna sarcóptica, miíase, alergia alimentar, dermatite piotraumática e malassezíase. Essas 10 condições perfizeram juntas aproximadamente 75% de todas as doenças de pele de cães diagnosticadas neste estudo, o que reforça a idéia corrente de que poucas doenças de pele são responsáveis pela maior parte dos atendimentos dermatológicos no município de Santa Maria.
APA, Harvard, Vancouver, ISO, and other styles
8

Winter, Randi P., Lorin Bibb, and Stuart S. Dr Leicht. "Pressure-induced Lipodystrophy from Elbow Compression." Digital Commons @ East Tennessee State University, 2019. https://dc.etsu.edu/asrf/2019/schedule/59.

Full text
Abstract:
Lipodystrophic syndromes encompass a wide range of both inherited and acquired conditions whereby adipose tissue is lost or absent. We report a rare case of acquired localized, pressure-induced lipodystrophy whereby continuous elbow pressure to the distal thighs led to marked tissue disfigurement. Pressure-induced lipodystrophy is a condition that likely results from protracted, localized pressure which ultimately decreases blood flow to the surrounding tissues. Overtime, the decreased perfusion is thought to induce adipocyte degeneration and eventual tissue deformation. Our findings resemble those described in the case reports of leg crossers’ dimples and lipoatrophia semicircularis and support current literature suggesting that prolonged pressure can indeed lead to significant adipose tissue loss and local architectural distortion. Our findings are significant because pressure-induced lipodystrophy represents an avoidable condition that can be circumvented if patients and physicians are knowledgeable of the underlying causes. We highlight a rare case report to educate the public as well as physicians about the causes of pressure-induced lipodystrophy and ultimately prevent future cases of unnecessary and unintended disfigurement.
APA, Harvard, Vancouver, ISO, and other styles
9

Castro, Eneida Lazzarini de 1955. "O conhecimento e o ensino sobre as doenças sexualmente transmissíveis entre os alunos da Unicamp." [s.n.], 2013. http://repositorio.unicamp.br/jspui/handle/REPOSIP/311632.

Full text
Abstract:
Orientador: Paulo Eduardo Neves Ferreira Velho
Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-24T04:23:44Z (GMT). No. of bitstreams: 1 Castro_EneidaLazzarinide_M.pdf: 1114056 bytes, checksum: a5208169cfed868777391385bab148e2 (MD5) Previous issue date: 2013
Resumo: Introdução: O ensino superior deve educar socialmente o cidadão, independente da sua área de conhecimento. As doenças sexualmente transmitidas (DST) são a principal causa global de doença aguda e morte e representam elevado custo socioeconômico. Os universitários são altamente expostos e ter outras infecções aumenta enormemente o risco de contrair o HIV. Objetivos: Avaliar o conhecimento de universitários sobre as DST, desenvolvendo um instrumento didático de autopercepção deste (des)conhecimento sobre o tema. Material e métodos: Um questionário foi enviado aos graduandos da Universidade Estadual de Campinas no final de 2011 e, em 2012, aos alunos recém-ingressos. Resultados e conclusões: Responderam o questionário 1.448 veteranos e 371 calouros. Metade era de cada sexo e houve representatividade de todas as áreas. Não tinham tido atividade sexual 20,0 e 38,0% dos veteranos e calouros, respectivamente. Dos alunos que já haviam tido, 26,9% não tinham parceria fixa e 28,2% mais que 2 parcerias/ano. A bissexualidade foi informada por 9,0% dos alunos, enquanto 5,8% dos homens e 1,1% das mulheres a homossexualidade. O preservativo foi usado por 99% dos alunos, mas menos de 20% deles fazia uso adequado do mesmo. Entre os alunos, 43% entenderam errado um slogan da campanha do governo. Cerca de 80% não sabiam que o preservativo não protege fora da área de barreira; não souberam identificar lesões de herpes simples e que não há cura para este vírus; quando apontadas lesões discretas da infecção pelo HPV, afirmaram que elas poderiam ser confundidas com "pintas"; pretendiam ler mais sobre DST e aprenderam algo sobre o assunto. Quase a metade dos alunos julgou que uma disciplina deveria ser oferecida a todos os graduandos. Vacinação pré-exposição poderia ter sido oferecida a mais de 43% dos calouros. Os dados encontrados serão úteis para definir estratégias de prevenção e o instrumento didático poderá ser utilizado em outros ambientes de ensino
Abstract: Higher education should educate students socially, regardless of their area of expertise. STDs are a global major cause of acute illness and death and represent high socioeconomic cost. Undergraduate students are highly exposed to them. Having other infection greatly increases the risk of contracting HIV. Our goals were to develop a teaching tool to generate perception of (un) knowledge about STDs and quantify that knowledge and the interest of the students in a course about this subject. A questionnaire was sent to students from State University of Campinas in late 2011 and, in 2012, to beginner students. The questionnaire was answered by 1,448 seniors and 371 freshmen. They were half of each gender and were representative of all areas. Twenty percent of seniors and 38,0% of freshmen had no sexual activity. Among the students that already had sexual activity, 26.9% had no regular partner and 28.2% had more than 2 partnerships a year. Bisexuality was reported by 9.0% of students, while 5.8% of men and 1.1% of female referred homosexuality. The condom was used by 99% of students, but less than 20% of them made proper use of it. Among the students, 43% misunderstood a slogan of the government campaign. About 80% of them did not know that condoms do not protect the outside barrier area; were not able to identify herpes simplex lesions and there is no cure for this virus; considered that discrete HPV lesions could be confused with nevus; wanted to read more about STDs; and learned something about the subject. Nearly half of the students felt that a course should be offered to all undergraduates. Pre-exposure vaccination could have been offered to more than 43% of freshmen. Our findings will be useful to help define strategies for prevention and the teaching tool might be used in other learning environments
Mestrado
Ensino em Saúde
Mestra em Clínica Médica
APA, Harvard, Vancouver, ISO, and other styles
10

Schielein, Maximilian [Verfasser], and Alexander [Akademischer Betreuer] Zink. "Mental health in dermatology: addictions in psoriasis and an outlook on the psychosocial burden of chronic skin diseases / Maximilian Schielein ; Betreuer: Alexander Zink." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2021. http://d-nb.info/1232645427/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Dermatology diseases"

1

O, Braun-Falco, ed. Dermatology. Berlin: Springer, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Dermatology. 3rd ed. Baltimore: Williams & Wilkins, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

1926-, Hurley Harry J., ed. Dermatology. 2nd ed. Philadelphia: Saunders, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Fry, L. Dermatology. Lancaster: MTP, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

1921-, Moschella Samuel L., and Hurley Harry J. 1926-, eds. Dermatology. 3rd ed. Philadelphia: Saunders, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Libby, Edwards, ed. Genital dermatology. New York: Churchill Livingstone, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

John, Savin, and Dahl Mark V, eds. Clinical dermatology. 2nd ed. Oxford: Blackwell Science, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Vulvovaginal dermatology. Philadelphia, Pa., [etc.]: Saunders, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

S, Shaw, ed. Dermatology. 2nd ed. Edinburgh: Churchill Livingstone, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Wilkinson, J. D. Dermatology. Edited by Shaw S and Bellman Betty. 2nd ed. Edinburgh: Churchill Livingstone, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Dermatology diseases"

1

Braun-Falco, Otto, Gerd Plewig, Helmut H. Wolff, and Richard K. Winkelmann. "Pustular Diseases." In Dermatology, 502–10. Berlin, Heidelberg: Springer Berlin Heidelberg, 1991. http://dx.doi.org/10.1007/978-3-662-00181-3_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Jain, Sima. "Infectious Diseases." In Dermatology, 195–256. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-47395-6_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Jain, Sima. "Infectious Diseases." In Dermatology, 169–229. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-0525-3_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Braun-Falco, Otto, Gerd Plewig, Helmut H. Wolff, and Walter H. C. Burgdorf. "Blistering Diseases." In Dermatology, 649–95. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-97931-6_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Braun-Falco, Otto, Gerd Plewig, Helmut H. Wolff, and Walter H. C. Burgdorf. "Pustular Diseases." In Dermatology, 697–708. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-97931-6_16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Braun-Falco, Otto, Gerd Plewig, Helmut H. Wolff, and Walter H. C. Burgdorf. "Viral Diseases." In Dermatology, 53–120. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-97931-6_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Braun-Falco, Otto, Gerd Plewig, Helmut H. Wolff, and Walter H. C. Burgdorf. "Rickettsial Diseases." In Dermatology, 121–26. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-97931-6_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Braun-Falco, Otto, Gerd Plewig, Helmut H. Wolff, and Walter H. C. Burgdorf. "Bacterial Diseases." In Dermatology, 127–244. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-97931-6_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Braun-Falco, Otto, Gerd Plewig, Helmut H. Wolff, and Walter H. C. Burgdorf. "Granulomatous Diseases." In Dermatology, 1379–400. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-97931-6_50.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Braun-Falco, Otto, Gerd Plewig, Helmut H. Wolff, and Walter H. C. Burgdorf. "Protozoan Diseases." In Dermatology, 299–312. Berlin, Heidelberg: Springer Berlin Heidelberg, 2000. http://dx.doi.org/10.1007/978-3-642-97931-6_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Dermatology diseases"

1

Greif, Charlotte, and Susanne Kammerer. "Dermatology diseases need the highest doses of biologics." In 2022 American Academy of Dermatology Annual Meeting, edited by Peter van de Kerkhof. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/b31d9b6b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Greif, Charlotte, and Susanne Kammerer. "Dermatology diseases need the highest doses of biologics." In 2022 American Academy of Dermatology Annual Meeting, edited by Peter van de Kerkhof. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/b8250abb.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Seo, Young-Seok, Junghyun Kim, and Daeyul Baek. "Development of high definition OCT system for clinical therapy of skin diseases." In Photonics in Dermatology and Plastic Surgery 2018, edited by Bernard Choi and Haishan Zeng. SPIE, 2018. http://dx.doi.org/10.1117/12.2289027.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Welzel, Julia, Maike Bruhns, Christina Schröder, and Reginald Birngruber. "Clinical OCT Studies in Dermatology: Inflammatory Skin Diseases and Treatment Effects." In Biomedical Topical Meeting. Washington, D.C.: OSA, 1999. http://dx.doi.org/10.1364/bio.1999.awb7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Rajkumar, N., and P. Jaganathan. "A new RBF kernel based learning method applied to multiclass dermatology diseases classification." In 2013 IEEE Conference on Information & Communication Technologies (ICT). IEEE, 2013. http://dx.doi.org/10.1109/cict.2013.6558156.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ginger Han, J., Blake Anderson, Ion Gireada, Jonathan Dyer, and Chi-Ren Shyu. "Case workflow and interaction studies of a tele-consultation system for rare dermatology diseases." In 2011 IEEE 13th International Conference on e-Health Networking, Applications and Services (Healthcom 2011). IEEE, 2011. http://dx.doi.org/10.1109/health.2011.6026765.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dalimunthe, Dina Arwina, Imam Budi Putra, and Nelva Karmila Jusuf. "Infectious and Non-infectious Skin Diseases Pattern in Dermatology and Venereology Department, Universitas Sumatera Utara Hospital, Medan, Indonesia in 2018." In The 2nd International Conference on Tropical Medicine and Infectious Disease. SCITEPRESS - Science and Technology Publications, 2019. http://dx.doi.org/10.5220/0009859000680071.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Azzini, Antonia, and Stefania Marrara. "Dermatology Disease Classification via Novel Evolutionary Artificial Neural Network." In 18th International Conference on Database and Expert Systems Applications (DEXA 2007). IEEE, 2007. http://dx.doi.org/10.1109/dexa.2007.4312875.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Azzini, Antonia, and Stefania Marrara. "Dermatology Disease Classification via Novel Evolutionary Artificial Neural Network." In 18th International Conference on Database and Expert Systems Applications (DEXA 2007). IEEE, 2007. http://dx.doi.org/10.1109/dexa.2007.71.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ajith, Archana, Vrinda Goel, Priyanka Vazirani, and M. Mani Roja. "Digital dermatology: Skin disease detection model using image processing." In 2017 International Conference on Intelligent Computing and Control Systems (ICICCS). IEEE, 2017. http://dx.doi.org/10.1109/iccons.2017.8250703.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography